Previous close | 24.00 |
Open | 23.97 |
Bid | 23.89 x 1000 |
Ask | 24.01 x 800 |
Day's range | 23.62 - 24.25 |
52-week range | 6.28 - 24.75 |
Volume | |
Avg. volume | 263,655 |
Market cap | 563.826M |
Beta (5Y monthly) | 1.22 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.20 |
Earnings date | 31 July 2023 - 04 Aug 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 27.33 |
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
MINNEAPOLIS, May 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 43rd Annual Growth Stock Conference, which is being held at the Loews Chicago Hotel in Chicago, IL from June 6th – 8th. Management will host a presentation with investors on Tuesday, June 6th at 8:00 a.m. Central Time. A live audio
Tactile Systems Technology ( NASDAQ:TCMD ) First Quarter 2023 Results Key Financial Results Revenue: US$58.8m (up 23...
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 88.89% and 8.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
First Quarter Revenue Increased 23% Year-Over-YearMINNEAPOLIS, May 08, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2023. First Quarter 2023 Summary: Total revenue increased 23% year-over-year to $58.8 million Lymphedema products revenue increased 22% year-over-yearAirway clearanc
MINNEAPOLIS, March 30, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2023 financial results will be released after the market opens on Monday, May 8. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on May 8 to discuss the results of the quarter. Those
MINNEAPOLIS, March 14, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Ms. Birkemeyer will succeed Brent Moen, who is retiring. “Elaine is a dynamic and purpose-driven leader with over 25 years of experience in finance, accounting,
MINNEAPOLIS, March 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences: The 33rd Oppenheimer Annual Healthcare Conference, which is being held virtually from March 13th-15th. Management will participate in a virtual fireside chat on Monday, March 13th at 12:40 p.m. Eastern
MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $13.00 per share. The gross proceeds to Tactile Medical from the offering, before deducting the underwriting disc
MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Tactile Medical intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock
We feel now is a pretty good time to analyse Tactile Systems Technology, Inc.'s ( NASDAQ:TCMD ) business as it appears...
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 107.14% and 4.82%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Fourth Quarter Revenue Increased 20% Year-Over-Year; Full Year Revenue Increased 19% Year-Over-YearMINNEAPOLIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Summary: Total revenue increased 20% year-over-year to $73.9 million, compared to $61.
MINNEAPOLIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that Brent Moen has communicated his intention to retire as Chief Financial Officer in 2023. “I would like to thank Brent for his important contributions to our organization during his tenure,” said Dan Reuvers, President and Chief Executive Officer of Tactile Medical.
MINNEAPOLIS, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Tuesday, February 21st. Management will host a conference call with a question and answer session at 8:00 a.m. Eastern Time on February 21st to discuss the results of the quarter. Th
To get a sense of who is truly in control of Tactile Systems Technology, Inc. ( NASDAQ:TCMD ), it is important to...
MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Carmen Volkart to the Company’s Board of Directors (“Board”), effective January 5, 2023. “Carmen joins our Board with more than 40 years of experience in financial and managerial positions, including extensive experience leading medical device companies,” said Bill
Investors need to pay close attention to Tactile Systems Technology (TCMD) stock based on the movements in the options market lately.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tactile Systems Technology (TCMD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Terex and Armstrong World Industries are part of the Zacks Bull and Bear of the Day article.
Here we discuss three medical instruments stocks - TCMD, VCYT and NVCN - that have started to recover in the past few months after declining for the major part of 2022.
Tactile Systems Technology, Inc. ( NASDAQ:TCMD ) shareholders should be happy to see the share price up 20% in the last...
ShockWave Medical, iRadimed and Tactile Systems Technology are part of the Zacks top Analyst Blog.
The consensus price target hints at a 168.2% upside potential for Tactile Systems Technology (TCMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here we discuss ShockWave Medical (SWAV), iRadimed (IRMD) and Tactile Systems Technology (TCMD), which have the potential to outperform their industry going forward.